- Report
- November 2022
- 286 Pages
Global
From €2507EUR$2,625USD£2,096GBP
€5014EUR$5,250USD£4,193GBP
- Report
- June 2022
- 257 Pages
Global
From €2507EUR$2,625USD£2,096GBP
€5014EUR$5,250USD£4,193GBP
- Report
- March 2022
- 273 Pages
Global
From €2507EUR$2,625USD£2,096GBP
€5014EUR$5,250USD£4,193GBP
- Report
- February 2024
- 75 Pages
Global
From €4727EUR$4,950USD£3,953GBP
- Report
- August 2023
- 150 Pages
Global
From €5682EUR$5,950USD£4,752GBP
- Report
- January 2024
- 200 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- November 2022
- 111 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- February 2024
- 245 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Report
- November 2023
- 630 Pages
Global
From €9073EUR$9,500USD£7,587GBP
- Report
- September 2022
- 239 Pages
Global
From €7163EUR$7,500USD£5,990GBP
- Report
- July 2023
- 140 Pages
Global
From €4726EUR$4,949USD£3,953GBP
- Report
- April 2023
- 120 Pages
Global
From €4536EUR$4,750USD£3,794GBP
- Report
- October 2023
- 177 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- March 2024
- 200 Pages
Global
From €3963EUR$4,150USD£3,314GBP
- Report
- June 2023
- 48 Pages
United States
From €573EUR$600USD£479GBP
- Report
- June 2023
- 48 Pages
United States
From €573EUR$600USD£479GBP
- Report
- June 2023
- 48 Pages
United States
From €716EUR$750USD£599GBP
- Report
- June 2023
- 48 Pages
United States
From €573EUR$600USD£479GBP
- Report
- June 2023
- 48 Pages
United States
From €573EUR$600USD£479GBP
- Report
- June 2023
- 48 Pages
United States
From €573EUR$600USD£479GBP

The Solid Tumor market within the context of Oncology is a highly competitive and rapidly evolving field. It is focused on the development of treatments for solid tumors, which are malignant tumors that form in the body's organs and tissues. These tumors can be caused by a variety of factors, including genetic mutations, environmental exposures, and lifestyle choices. Treatment options for solid tumors include surgery, chemotherapy, radiation therapy, and targeted therapies.
The Solid Tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. Companies in this market are focused on developing innovative treatments and therapies to improve patient outcomes. Examples of companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more